Literature DB >> 25511759

Renal transplantation in 2014: renal transplantation-reducing risk and improving outcome.

Dennis A Hesselink1, Willem Weimar1.   

Abstract

Several studies published in 2014 might facilitate improvements in the treatment and long-term care of renal transplant recipients. The potential risks of living kidney donation, the efficacy and safety of alemtuzumab-based induction therapy, and the treatment of chronic hepatitis E virus infection have been addressed.

Entities:  

Mesh：

Year:  2014        PMID： 25511759     DOI： 10.1038/nrneph.2014.240

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Authors:  Robert D Morgan; John M O'Callaghan; Simon R Knight; Peter J Morris
Journal:  Transplantation       Date:  2012-06-27       Impact factor: 4.939

2.  Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation.

Authors:  W S Cherikh; C J Young; B F Kramer; S E Taranto; H B Randall; P-Y Fan
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

3.  Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.

Authors:  Nassim Kamar; Cyril Garrouste; Elizabeth B Haagsma; Valérie Garrigue; Sven Pischke; Cécile Chauvet; Jérome Dumortier; Amélie Cannesson; Elisabeth Cassuto-Viguier; Eric Thervet; Filomena Conti; Pascal Lebray; Harry R Dalton; Robert Santella; Nada Kanaan; Marie Essig; Christiane Mousson; Sylvie Radenne; Anne Marie Roque-Afonso; Jacques Izopet; Lionel Rostaing
Journal:  Gastroenterology       Date:  2011-02-24       Impact factor: 22.682

4.  Alemtuzumab induction in renal transplantation.

Authors:  Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

5.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

6.  Long-term risks for kidney donors.

Authors:  Geir Mjøen; Stein Hallan; Anders Hartmann; Aksel Foss; Karsten Midtvedt; Ole Øyen; Anna Reisæter; Per Pfeffer; Trond Jenssen; Torbjørn Leivestad; Pål-Dag Line; Magnus Øvrehus; Dag Olav Dale; Hege Pihlstrøm; Ingar Holme; Friedo W Dekker; Hallvard Holdaas
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

7.  Risk of end-stage renal disease following live kidney donation.

Authors:  Abimereki D Muzaale; Allan B Massie; Mei-Cheng Wang; Robert A Montgomery; Maureen A McBride; Jennifer L Wainright; Dorry L Segev
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

8.  Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Authors:  Nassim Kamar; Jacques Izopet; Simona Tripon; Michael Bismuth; Sophie Hillaire; Jérôme Dumortier; Sylvie Radenne; Audrey Coilly; Valérie Garrigue; Louis D'Alteroche; Matthias Buchler; Lionel Couzi; Pascal Lebray; Sebastien Dharancy; Anne Minello; Maryvonne Hourmant; Anne-Marie Roque-Afonso; Florence Abravanel; Stanislas Pol; Lionel Rostaing; Vincent Mallet
Journal:  N Engl J Med       Date:  2014-03-20       Impact factor: 91.245

9.  Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.

Authors:  Richard Haynes; Paul Harden; Parminder Judge; Lisa Blackwell; Jonathan Emberson; Martin J Landray; Colin Baigent; Peter J Friend
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321

10.  Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.

Authors:  Richard Haynes; Colin Baigent; Paul Harden; Martin Landray; Murat Akyol; Argiris Asderakis; Alex Baxter; Sunil Bhandari; Paramit Chowdhury; Marc Clancy; Jonathan Emberson; Paul Gibbs; Abdul Hammad; Will Herrington; Kathy Jayne; Gareth Jones; Nithya Krishnan; Michael Lay; David Lewis; Iain Macdougall; Chidambaram Nathan; James Neuberger; Chas Newstead; Ravi Pararajasingam; Carmelo Puliatti; Keith Rigg; Peter Rowe; Adnan Sharif; Neil Sheerin; Sanjay Sinha; Chris Watson; Peter Friend
Journal:  Transplant Res       Date:  2013-05-06
  10 in total
  2 in total

1.  Ultrasound Assessment of Intima-media Thickness and Diameter of Carotid Arteries in Patients Undergoing Hemodialysis or Renal Transplantation.

Authors:  Zhao-Jun Li; Lian-Fang Du; Yan Qin; Ji-Bin Liu; Xiang-Hong Luo
Journal:  Curr Med Sci       Date:  2018-08-20

2.  IL-21 Receptor Antagonist Inhibits Differentiation of B Cells toward Plasmablasts upon Alloantigen Stimulation.

Authors:  Kitty de Leur; Frank J M F Dor; Marjolein Dieterich; Luc J W van der Laan; Rudi W Hendriks; Carla C Baan
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.